The clinical and experimental studies of Chanle Chongji for reducing bleeding after abortion
Zhao, R.; Ding, Y.; Hu, Y.
Reproduction and Contraception 10(2): 113-120
1999
ISSN/ISBN: 1001-7844 PMID: 12322338 Document Number: 506263
This report presents the results of the clinical and experimental studies conducted to determine the effectiveness of ChanLe Chongji, a Chinese medicine. ChanLe Chongji is believed to promote uterine contraction, stop bleeding, resist bacteria and diminish inflammation. The clinical study was done on 100 women with the following characteristics: under 35 years old; in good health; no contraindication to mifepristone and prostaglandin; normal menses for the past 3 months; not more than 49 days after amenorrhea; intrauterine pregnancy diagnosed by urine human chorionic gonadotropin or ultrasonography. These women were divided into two groups (treated group and control group). An experimental portion of the study included kunming mice weighing 25-30 g and on Wistar rats weighing 180-230 g. The results of the clinical study revealed that the mean bleeding period in the treated group was 8.4 days, while it was 13.3 days in the control group. The mean complete abortion rate was 95% in the treated group and 88% in the control group. A pharmacodynamic test was conducted during the animal experimental portion to comprehend the mechanism of hemostasis. It showed that ChanLe Chongji could increase uterine contraction and stop bleeding; maximal dosage also demonstrated that ChanLe Chongji was safe in clinical use.